Atara Biotherapeutics (ATRA) Revenue (2021 - 2026)
Atara Biotherapeutics' Revenue came in at $630,000 for Q2 2026, down 96.4% from $17.58 million a year earlier but up 22.1% from the prior quarter.
Atara Biotherapeutics (ATRA) Revenue (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Atara Biotherapeutics reported Revenue of $6.19 million, down 96.7% year-over-year; for FY2025, it came in at $120.77 million, down 6.3% from FY2024.
- Revenue carries a four-year compound annual growth rate of 56.1% (FY2021 to FY2025).
- Going back by year, Revenue was $128.94 million in FY2024, $8.57 million in FY2023 (-86.5%), $63.6 million in FY2022 (+212.7%) and $20.34 million in FY2021.
- The five-year range for quarterly Revenue is $248,000 (Q4 2022) to $98.15 million (Q1 2025).
- Year-over-year, Revenue has declined for five consecutive quarters, with growth averaging 72.6% over the last seven quarters.
- The fastest year-over-year change in Revenue over five years came in Q4 2024 (growth of 670.3%), and the weakest in Q1 2026 (a decline of 99.5%).
- Business Quant data shows ATRA's Revenue at $516,000 (Q1 2026), $1.6 million (Q4 2025) and $3.45 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Atara Biotherapeutics | 127.78 Mn | 117.88 Mn | 439,000.00 | 630,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 630,000.00 |
| Mar 31, 2026 | 516,000.00 |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 3.45 Mn |
| Jun 30, 2025 | 17.58 Mn |
| Mar 31, 2025 | 98.15 Mn |
| Dec 31, 2024 | 32.75 Mn |
| Sep 30, 2024 | 40.19 Mn |
| Jun 30, 2024 | 28.64 Mn |
| Mar 31, 2024 | 27.36 Mn |
| Dec 31, 2023 | 4.25 Mn |
| Sep 30, 2023 | 2.14 Mn |
| Jun 30, 2023 | 957,000.00 |
| Mar 31, 2023 | 1.23 Mn |
| Dec 31, 2022 | 248,000.00 |
| Sep 30, 2022 | 4.46 Mn |
| Jun 30, 2022 | 51.58 Mn |
| Mar 31, 2022 | 7.31 Mn |
| Dec 31, 2021 | 7.55 Mn |
| Sep 30, 2021 | 5.37 Mn |
Atara Biotherapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ATRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();